IP Library Granted Patent US 11,078,248
Granted Patent B2
US 11,078,248 · App. 16/218,979 · Granted Aug 3, 2021

BMP peptides and methods of use

Inventors: Xiaofei Qin (Virginia Beach, VA); Silvia Chen (Kendall Park, NJ); Jingsong Chen (Virginia Beach, VA); James Clagett (Virginia Beach, VA)
Assignee: LifeNet Health
C07K14/51A61K38/1875A61K38/48C12N5/0602C12N5/0654C12N5/0655C12N5/0658C12N9/48A61K38/00C12N2501/155C12N2506/1323C12N2510/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,078,248
App. No.
16/218,979
Granted
Aug 3, 2021
Kind
B2
Abstract

The invention relates to truncated growth factors and variants thereof. The invention also relates to methods of making and using the truncated growth factors. The invention further relates to compositions including a protease and a growth factor comprising a bone morphogenic protein (BMP) or a variant thereof. The invention also relates to methods of using the composition.

Claims (8)

1. A method of promoting differentiation of cells into osteoblasts or chondrocytes, the method comprising treating the cells with a peptide consisting of the amino acid sequence of SEQ ID NO: 19.

2. The method of claim 1 , wherein the cells are progenitor cells or adult stem cells.

3. The method of claim 2 , wherein the progenitor cells or the adult stem cells are derived from placenta, bone marrow, adipose tissue, blood vessel, amniotic fluid, synovial fluid, synovial membrane, pericardium, periosteum, dura, peripheral blood, umbilical blood, menstrual blood, baby teeth, nucleus pulposus, brain, skin, hair follicle, intestinal crypt, neural tissue, or muscle.

4. The method of claim 1 , wherein the cells are induced pluripotent stem cells.

5. A method of promoting osteogenesis of cells in a tissue, the method comprising treating the tissue with

a peptide consisting of the amino acid sequence of SEQ ID NO: 19.

6. The method of claim 5 , wherein the osteogenic activity of cells in the treated tissue is greater than the osteogenic activity of cells in untreated tissue.

7. The method of claim 5 , wherein the tissue is bone tissue or connective tissue.

Assignments (2)
SECURITY INTEREST Recorded Apr 2, 2021
From: LIFENET HEALTH; SKIN AND WOUND ALLOGRAFT INSTITUTE, LLC
To: TRUIST BANK
Reel/Frame 055815/0623 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2019
From: QIN, XIAOFEI; CHEN, SILVIA; CHEN, JINGSONG; CLAGETT, JAMES
To: LIFENET HEALTH
Reel/Frame 048481/0425 →